[1] |
Folli F, Kahn CR, Hansen H, et al. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk [J]. J Clin Invest, 1997, 100(9): 2158-2169.
|
[2] |
Motley ED, Eguchi K, Gardner C, et al. Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha [J]. Hypertension, 2003, 41(3 Pt 2): 775-780.
|
[3] |
Simon F, Varela D, Cabello-Verrugio C, et al. Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans [J]. Cell Signal, 2013, 25(7): 1614-1624.
|
[4] |
Wei Y, Sowers JR, Clark SE, et, al. Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase [J]. Am J Physiol Endocrinol Metab, 2008, 294(2): E345-351.
|
[5] |
Csibi, Communi D, Muller N, et al. Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms [J]. PLoS One, 2010, 5(4): e10070.
|
[6] |
Diamond-Stanic MK, Henriksen EJ. Direct inhibition by angiotensin Ⅱ of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism [J]. Arch Physiol Biochem, 2010, 116(2): 88-95.
|
[7] |
Blair AB, Hajduch E, Litherland GJ, et, al. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways [J]. J Biol Chem, 1999, 274(51): 36293-36299.
|
[8] |
Santos FR, Diamond-Stanic MK, Prasannarong M, et al. Contribution of the serine kinase c-Jun N-terminal kinase(JNK) to oxidant-induced insulin resistance in isolated rat skeletal muscle [J]. Arch Physiol Biochem, 2012, 118(5): 231-236.
|
[9] |
Skurk T, van Harmelen V, Hauner H, et al. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB [J]. Arterioscler Thromb Vasc Biol, 2004, 24(7): 1199-1203.
|
[10] |
Asamizu S, Urakaze M, Kobashi C, et, al. Angiotensin II enhances the increase in monocyte chemoattractant protein-1 production induced by tumor necrosis factor-{alpha} from 3T3-L1 preadipocytes [J]. J Endocrinol, 2009, 202(2): 199-205.
|
[11] |
Lee MH, Song HK, Ko GJ, et, al. Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue [J]. Kidney Int, 2008, 74(7): 890-900.
|
[12] |
Tikellis, Wookey PJ, Candido R, et, al. Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat [J]. Diabetes, 2004, 53(4): 989-997.
|
[13] |
Leung PS, Carlsson PO. Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus [J]. Pancreas, 2005, 30(4): 293-298.
|
[14] |
Darimont, G. Vassaux, G. Ailhaud, et, al. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-Ⅱ [J]. Endocrinology, 1994, 135(5): 2030-2036.
|
[15] |
Fuentes P, Acuna MJ, Cifuentes M, et al. The anti-adipogenic effect of angiotensin II on human preadipose cells involves ERK1, 2 activation and PPARG phosphorylation [J]. J Endocrinol, 2010, 206(1): 75-83.
|
[16] |
Mazak, Fiebeler A, Muller DN, et al. Aldosterone potentiates angiotensin Ⅱ-induced signaling in vascular smooth muscle cells [J]. Circulation, 2004, 109(22): 2792-2800.
|
[17] |
Ishizawa, Izawa Y, Ito H, et, al. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation [J]. Hypertension, 2005, 46(4): 1046-1052.
|
[18] |
Fu GX, Xu CC, Zhong Y, et, al. Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK [J]. Endocrine, 2012, 42(3): 676-683.
|
[19] |
Miyata K, Hitomi H, Guo P, et, al. Possible involvement of Rho-kinase in aldosterone-induced vascular smooth muscle cell remodeling [J]. Hypertens Res, 2008, 31(7): 1407-1413.
|